title: J&J stock falls on earnings: Why this analyst is still bullish
source: Yahoo
date: 2025-10-14
url: https://finnhub.io/api/news?id=05e1df074dfe8c87d3d525dc46b138638ffcd9595f96deea337d800e77858bdf
Johnson & Johnson (JNJ) stock is in focus after the company reported earnings and announced a spin-off of its orthopedics business. Guggenheim Securities senior research analyst and managing director Vamil Divan joins Market Catalysts to examine the earnings print, discuss what's driving the stock lower, and outline his bullish case for the stock. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.
